Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelofibrosis, Primary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Testing effectiveness (Phase 2)Looking for participantsNCT05980806
What this trial is testing

Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

Who this might be right for
MyelofibrosisModerate ThrombocytopeniaMild Thrombocytopenia
Karyopharm Therapeutics Inc 58
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Very early researchStudy completedNCT03426969
What this trial is testing

Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis

Who this might be right for
Primary MyelofibrosisSecondary Myelofibrosis
M.D. Anderson Cancer Center 3
Not applicableLooking for participantsNCT05875805
What this trial is testing

A Telehealth Advance Care Planning Intervention

Who this might be right for
Myeloid MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes+2 more
University of Rochester 207
Not applicableUnknownNCT01816022
What this trial is testing

Myeloproliferative Neoplasms and Bone Structure

Who this might be right for
Polycythemia VeraThrombocythemia, EssentialPrimary Myelofibrosis
University of Southern Denmark 125
Testing effectiveness (Phase 2)Ended earlyNCT02410551
What this trial is testing

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

Who this might be right for
Myeloproliferative Diseases
M.D. Anderson Cancer Center 4
Not applicableStudy completedNCT01758042
What this trial is testing

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Who this might be right for
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)+14 more
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT01420770
What this trial is testing

Phase 2 Study of SAR302503 in Patients With Myelofibrosis

Who this might be right for
Hematopoietic Neoplasm
Bristol-Myers Squibb 30
Testing effectiveness (Phase 2)Study completedNCT02420873
What this trial is testing

An Open-label Phase II Study of Lorvotuzumab Mertansine

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 9
Early research (Phase 1)Study completedNCT00438178
What this trial is testing

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

Who this might be right for
Hematological Malignancies
Gemin X 44
Early research (Phase 1)Ended earlyNCT02436135
What this trial is testing

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed Disease

Who this might be right for
Myelofibrosis
Gilead Sciences 10
Testing effectiveness (Phase 2)UnknownNCT00668421
What this trial is testing

CEP-701 (Lestaurtinib) in Myelofibrosis

Who this might be right for
MyelofibrosisEssential ThrombocythemiaPolycythemia Vera
Ronald Hoffman 60
Early research (Phase 1)Study completedNCT06132243
What this trial is testing

Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions

Who this might be right for
Myelofibrosis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 52
Testing effectiveness (Phase 2)Study completedNCT04851535
What this trial is testing

Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.

Who this might be right for
Myelofibrosis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 34
Early research (Phase 1)Ended earlyNCT00522574
What this trial is testing

A Safety Study of XL019 in Adults With Myelofibrosis

Who this might be right for
Myeloproliferative DisordersMyelofibrosisPolycythemia Vera+1 more
Exelixis 100
Large-scale testing (Phase 3)UnknownNCT03662126
What this trial is testing

KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment

Who this might be right for
Primary Myelofibrosis (PMF)Post-Polycythemia Vera MF (Post-PV-MF)Post-Essential Thrombocythemia MF (Post-ET-MF)
Kartos Therapeutics, Inc. 385
Large-scale testing (Phase 3)Study completedNCT03480360
What this trial is testing

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more
Dartmouth-Hitchcock Medical Center 21
Not applicableWithdrawnNCT00499668
What this trial is testing

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+5 more
Vanderbilt-Ingram Cancer Center
Next Page